Safety alert on sodium nitrite

A National Patient Safety Alert has been issued on the risk of death from unintended administration of sodium nitrite.

Sodium nitrite has one licensed indication: as an antidote to cyanide poisoning. It can cause significant side effects and is categorised as highly toxic. It should only be available in Emergency Departments.

Incidents have been reported where sodium nitrite was inadvertently administered instead of sodium bicarbonate, and other sodium containing injections. As the packaging and labelling of sodium bicarbonate ampoules are similar to unlicensed sodium nitrite ampoules, mis-selection errors are likely to be due to the inadvertent supply of sodium nitrite outside of Emergency Departments.

NHS acute trusts are asked to remove sodium nitrite injections from all clinical areas except Emergency Departments and replace unlicensed sodium nitrite ampoules with licensed sodium nitrite vials. Pharmacies and Emergency Departments are also asked to change procedures and storage policies for all ‘specialist antidotes’.

Latest Issues

AfPP Newcastle Regional Conference

Herschel Building, Newcastle University
26th April 2025

GS1 UK Healthcare Conference

QEII Centre, London Westminster
29th – 30th April 2025

Infection Prevention and Control 2025 Conference and Exhibition

The National Conference Centre, Birmingham
29th – 30th April 2025

Decontamination and Sterilisation 2025 Conference and Exhibition

The National Conference Centre, Birmingham
29th April 2025

Scottish Intensive Care Society Conference 2025

Crieff Hydro Hotel, Scotland
1st - 2nd May 2025

AfPP Plymouth Regional Conference

TBC, Plymouth
10th May 2025